Alexander D. Gitlin,Klaus Heger,Alexander F. Schubert,Rohit Reja,Donghong Yan,Victoria C. Pham,Eric Suto,Juan Zhang,Youngsu C. Kwon,Emily C. Freund,Jing Kang,Anna Pham,Roger Caothien,Natasha Bacarro,Trent Hinkle,Min Xu,Brent S. McKenzie,Benjamin Haley,Wyne P. Lee,Jennie R. Lill,Merone Roose-Girma,Monika Dohse,Joshua D. Webster,Kim Newton,Vishva M. Dixit

Abstract:Mutations in the death receptor FAS 1 , 2 or its ligand FASL 3 cause autoimmune lymphoproliferative syndrome, whereas mutations in caspase-8 or its adaptor FADD—which mediate cell death downstream of FAS and FASL—cause severe immunodeficiency in addition to autoimmune lymphoproliferative syndrome 4 – 6 . Mouse models have corroborated a role for FADD–caspase-8 in promoting inflammatory responses 7 – 12 , but the mechanisms that underlie immunodeficiency remain undefined. Here we identify NEDD4-binding protein 1 (N4BP1) as a suppressor of cytokine production that is cleaved and inactivated by caspase-8. N4BP1 deletion in mice increased the production of select cytokines upon stimulation of the Toll-like receptor (TLR)1–TLR2 heterodimer (referred to herein as TLR1/2), TLR7 or TLR9, but not upon engagement of TLR3 or TLR4. N4BP1 did not suppress TLR3 or TLR4 responses in wild-type macrophages, owing to TRIF- and caspase-8-dependent cleavage of N4BP1. Notably, the impaired production of cytokines in response to TLR3 and TLR4 stimulation of caspase-8-deficient macrophages 13 was largely rescued by co-deletion of N4BP1. Thus, the persistence of intact N4BP1 in caspase-8-deficient macrophages impairs their ability to mount robust cytokine responses. Tumour necrosis factor (TNF), like TLR3 or TLR4 agonists, also induced caspase-8-dependent cleavage of N4BP1, thereby licensing TRIF-independent TLRs to produce higher levels of inflammatory cytokines. Collectively, our results identify N4BP1 as a potent suppressor of cytokine responses; reveal N4BP1 cleavage by caspase-8 as a point of signal integration during inflammation; and offer an explanation for immunodeficiency caused by mutations of FADD and caspase-8.

Mechanism of Negative Regulation of NF-κB by N4BP1

N4BP1 Negatively Regulates NF-κB by Binding and Inhibiting NEMO Oligomerization

Trim30 Alpha Negatively Regulates Tlr-Mediated Nf-Kappa B Activation By Targeting Tab2 And Tab3 For Degradation

NLRP4 Negatively Regulates Type I Interferon Signaling by Targeting the Kinase TBK1 for Degradation Via the Ubiquitin Ligase DTX4

TRIM30α negatively regulates TLR-mediated NF-κB activation by targeting TAB2 and TAB3 for degradation

TRIM 30 a negatively regulates TLR-mediated NF-j B activation by targeting TAB 2 and TAB 3 for degradation

N4BP1 coordinates ubiquitin-dependent crosstalk within the IκB kinase family to limit Toll-like receptor signaling and inflammation

Integration of Innate Immune Signalling by Caspase-8 Cleavage of N4BP1.

IKIP Negatively Regulates NF-κB Activation and Inflammation Through Inhibition of IKKα/β Phosphorylation

USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms

The 11S Proteasome Subunit PSME3 is a Positive Feedforward Regulator of NF-κB and Important for Host Defense Against Bacterial Pathogens.

Negative Regulation of NF-κB Activity by Brain-Specific TRIpartite Motif Protein 9

RNF4 Negatively Regulates NF‐κB Signaling by Down‐regulating TAB2

NLRX1 Negatively Regulates TLR-Induced NF-κB Signaling by Targeting TRAF6 and IKK

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

N-Myc-Interacting Protein Negatively Regulates TNF-α-Induced NF-κB Transcriptional Activity by Sequestering NF-κB/p65 in the Cytoplasm

The E3 Ligase RNF34 is a Novel Negative Regulator of the NOD1 Pathway

RNF144B inhibits LPS-induced inflammatory responses via binding TBK1

Ncf1 provides a reactive oxygen species-independent negative feedback regulation of TLR9-induced IL-12p70 in murine dendritic cells.

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

KIZ/GM114 Balances the NF-ĸB Signaling by Antagonizing the Association of TRAF2/6 with Their Upstream Adaptors